Role of P-glycoprotein at the blood-testis barrier on adjudin distribution in the testis a revisit of recent data

Advances in Experimental Medicine and Biology

Volumn 763, Issue , 2013, Pages 318-333

  Su, Linlin ^a   Jenardhanan, Pranitha ^b   Mruk, Dolores D ^a   Mathur, Premendu P ^b   Cheng, Yan Ho ^c   Mok, Ka Wai ^a   Bonanomi, Michele ^d   Silvestrini, Bruno ^d   Cheng, C Yan ^a  

^a POPULATION COUNCIL   (United States)

^b PONDICHERRY UNIVERSITY   (India)

^c RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

^d SBM Srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUDIN; FOCAL ADHESION KINASE; MALE CONTRACEPTIVE AGENT; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BLOOD TESTIS BARRIER; CELL ADHESION; CELL LOSS; CELLULAR DISTRIBUTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; GERM CELL; HUMAN; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TERTIARY STRUCTURE; SEMINIFEROUS TUBULE EPITHELIUM; SERTOLI CELL; TISSUE DISTRIBUTION;

EID: 84934444369     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4711-5_16     Document Type: Article

References (41)

1. Cheng CY, Mruk DD. The blood-Testis barrier and its implication in male contraception. Phannacol Rev 2012; 64, A-AW
2. Pelletier RM. The blood-Testis barrier: The junctional penneability, the proteins and the lipids. Prog Histochem Cytochcm 2011; 46:49-127
3. Mital P, Hinton BT, Dufour 1M. The blood-Testis and blood-epididymis barriers are more than just their tight junctions. BioI Rcprod 2011; 84:851-858
4. Franca LR, Auharek SA, Hess RA, et al. Morphofunctional and immunological aspects ofthe blood-Testis and blood-epididymal barriers. In: Biology and Regulation of Blood-Tissue Barriers. Ed. Cheng C. Y. Austin, TX, Landes Bioscience and Springer Science + Business Media, LLC. http://www. landesbioscience. com/curie/chapter/5148/20 I.I.
5. Easton AS. Regulation of permeability across the blood-brain barrier. In: Biology and Regulation of Blood-Tissue Barriers. Ed. Cheng CY. Austin TX, Landes Bioscience and Springer Science Business Media, LLC. (in press) 2011
6. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005; 57: 173-185
7. Cheng CY, Mruk DD. A local autocrine axis in the testes that regulates spermatogenesis. Nature Rev Endocrinol 2010; 6:380-395
8. Mruk DD, Cheng CY. Delivering nonhormonal contraceptives to men: Advances and obstacles. Trends Biotechnol 2008;26: 90-99
9. Setchell BP. Blood-Testis barrier, functional and transport proteins and spermatogenesis. Adv Exp Med Bioi 2008; 636: 212-233
10. Cheng CY, et al. AF-2364 [1-(2,4-dichlorobenzyl)-IH-indazole-3- carbohydrazide] is a potential male contraceptive: A review ofrecent data. Contraception 2005;72:251-261
11. Cheng CY, et al. Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis. BioI Reprod 2001; 65:449-461
12. Mruk DD, Silvestrini B, Cheng CY. Anchoringjunctions as drug targets: Role in contraceptive development. Pharmacol Rev 2008; 60: 146-180
13. Su L, Mruk DD, Cheng CY. Drug transporters, the blood-Testis barrier and spermatogenesis.] Endocrinol 2011; 208:207-223
14. Kis 0, Robillard K, Chan GN, et al. The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters. Trends Pharmacol Sci 2010; 31 :22-35
15. DeGorter MK, Xia CQ, Yang JJ, et al. Drug transporters in drug efficacy and toxicity. AnnuRev Pharmacol Toxciol (in press; DOI:IO.I 146/annurev- pharmtox-01061 1-134529) 2012
16. Mandery K, Glaeser H, Fromm M. Interaction of innovative small molecule drugs used for cancer theraphy with drug transporters. BrJ Pharmacol (in press, doi: I 0.11 I I/j. 1476-538 1.20 11.01618.x) 2011
17. Mruk DD, Su L, Cheng CY. Emerging role for drug transporters at the blood-Testis barrier. Trends Pharmacol Sci 2011; 32:99-106
18. Su L, Cheng CY, Mruk DD. Drug transporter, P-glycoprotein (MDRI), is an integrated component of the mammalian blood-Testis barrier. Tnt J Biochem Cell BioI 2009; 41 :2578-2587
19. Su L, Mruk DD, Lui WY, et al. P-glycoprotein regulates blood-Testis barrier dynamics via its effects on the occludin/zonula occludens I (ZO-I) protein complex mediated by focal adhesion kinase (FAK). Proc Natl Acad Sci USA 2011; In press: DOl: 10. 1073/pnas. I 11 1414108
20. Boutros T, Chevet E, Metrakos P. Mitogen-Activated protein (MAP) kinase/MAP kinase phosphatase regulation: Roles in cell growth, death and cancer. Pharmacol Rev 2008; 60:261-310
21. Cheng CY, Mruk DD. Regulation of blood-Testis barrier dynamics by focal adhesion kinase (FAK). An unexpected tum of events. Cell Cycle 2009; 8:3493-3499
22. Belvitch P, Dudek SM. Role ofFAK in SIP-regulated endothelial permeability. Microvasc Res (in press; doi: 10. 10 I 6/j.mvr.20 11.08.0 12) 2011
23. Grinnell KL, Harrington EO. Microvasc Res (in press; doi: 10.10 16/j.mvr.2011.04.005). (Interplay between F AK, PKCd and p 190RhoGAP in the regulation of endothelial barrier function
24. Siu ER, et al. An occludin-focal adhesion kinase protein complex at the blood-Testis barrier: A study using the cadmium model. Endocrinology 2009; 150:3336-3344
25. Siu ER, Wong EWP, Mruk DD, et al. Focal adhesion kinase is a blood-Testis barrier regulator. Proc Natl Acad Sci USA 2009; 106:9298-9303
26. Siu MKY, Wong CH, Lee WM, et al. Sertoli-germ cell anchoringjunction dynamics in the testis are regulated by an interplay oflipid and protein kinases.] BioI Chern 2005; 280:25029-25047
27. Lee NPY, Cheng CY. Regulation ofSertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3' ,5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: An in vitro study. Endocrinology 2003; 144:3114-3129
28. Melaine N, et al. Multidrug resistance genes and P-glycoprotein in the testis of the rat, mouse, guinea pig and human. Bioi Reprod 2002; 67:1699-1707
29. Bart J, et al. The distribution of drug-efflux pumps, P-gp, BCRP, MRP I andMRP2, in the normal blood-Testis barrier and in primary testicular tumours. Eur J Cancer 2004; 40:2064-2070
30. Su L, Mruk DD, Lee WM, et al. Drug transporters and blood-Testis barrier function. ] Endocrinol 20 II; 209:337-351
31. Altschul SF, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acid Res 1997; 25:3389-3402
32. Bennan HM, et al. The Protein Data Bank. Nueleic Acid Res 2000; 28:235-242
33. Laskowski RA, Rullmann JAC, MacArthur MW et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996; 8:477-486
34. Colovos C, Y catcs TO. V crification of protcin structurcs: Pattcrns of nonbondcd atomic intcractions. Protein Sci 1993; 2:1511-1519
35. Allcr SG et al. Structurc ofP-glycoprotcin rcvcals a molecular basis for poly-spccific drug binding. Scicncc 2009; 323: 1718-1722
36. Laskowski RA. PDBsum ncw things. Nucleic Acid Rcs 2009; 37:D355-D359
37. Globisch C, Pajeva IK, Wiese M. Identification of putative binding sites of P-glycoprotein based on its homology modcl. ChcmMcdChcm 2008: 3:280-295
38. Dawson RJ, Locher KP. Structure of the multidrug ABC tamsporter Savl866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lctt 2007; 581 :935-938
39. Pohl A, Devaux PF, Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim Biophys Acta 2005; 1733:29-52
40. Shapiro AB, Ling V. Extraction of Hoechst 33342 and the cytoplasmic leaflet of the plasma membrane by P-glycoprotcin. Eur J Biochcm 1997; 250:122-129
41. Robillard KR, Hoque MdT, Bendayan R. Expression of A TP binding cassette membrane transporters in rodcnt and human Scrtoli cclls: Relcvancc to thc pcrmcability of antirctroviral thcrapy at thc blood-Tcstis barrier. J Phannacol Exp Ther 20 II; In press: DOT: I 0.1 I 24/jpet. I 11.186916